Nanobiotix S.A. (NBTX) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nanobiotix Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.049 -- 00:00:05.494 Good day, and thank you for standing by. Welcome to the Nanobiotics Business Update 00:00:05.494 -- 00:00:08.016 and Third Quarter 2023 Conference 00:00:08.016 -- 00:00:12.159 Call. At this time, all participants are in listen-only mode. 00:00:12.159 -- 00:00:16.322 After the speakers' presentations, there will be a question-and-answer session. 00:00:16.322 -- 00:00:19.525 Please be advised that today's conference is being recorded. 00:00:19.525 -- 00:00:23.909 At this point, I will turn the call over to Craig West, Senior Vice President of Investor 00:00:23.909 -- 00:00:26.709 Relations of Nanobiotics. 00:00:26.931 -- 00:00:32.469 Thank you, Operator. Good afternoon and good morning, and welcome to the Nanobiotics 00:00:32.469 -- 00:00:36.732 Conference call to discuss our third quarter 2023 00:00:36.732 -- 00:00:42.996 financial and operating results and the clinical data presented at this year's ESMO conference. 00:00:42.996 -- 00:00:48.720 Joining me on the call today are Laurent Levy, co-founder and chief executive officer, 00:00:48.720 -- 00:00:52.302 and Bart Van Ryn, chief financial officer. 00:00:52.302 -- 00:00:57.006 As a reminder, today's call is being webcast and will be available on our website for 00:00:57.006 -- 00:01:02.006 replay. Moving on to slide number two, I would like to remind you 00:01:02.006 -- 00:01:06.488 that this call will include forward-looking statements, which may include statements 00:01:06.488 -- 00:01:11.690 regarding the progress, success, and timing of our ongoing and planned clinical 00:01:11.690 -- 00:01:17.352 trials, collaborations, regulatory filings, dates of presentation, 00:01:17.352 -- 00:01:21.973 and future research and development efforts, among other things. 00:01:21.973 -- 00:01...